-
Revenue Down, Margins Up: Lifeist's Q1 Financial Results Show Focus On Premium Products Curbed Revenue Drop
Tuesday, April 30, 2024 - 1:12pm | 584Lifeist Wellness Inc. (OTCQB:LFSWF) (TSXV:LFST), a Toronto-based cannabis and health-tech company, announced its financial results for the three months ended February 29, 2024. The company reported net revenue of CA$4.9 million ($3.6 million), a decrease from CA$5.9 million in the same period last...
-
Lifeist Q2 FY23 Net Revenue Grows 51% YoY, What About Adjusted EBITDA?
Friday, July 28, 2023 - 9:35am | 531Lifeist Wellness Inc. (OTCMKTS:LFSWF) (TSXV:LFST) (FRANKFURT:M5B) released its financial results for the three months ended May 31, 2023, revealing net revenue of CA$6.2 million ($4.7 million), an increase of 51% compared to CA$4.1 million in Q2 2022. The improvement was mainly driven by a year-...
-
Lifeist Q1 FY23 Revenue Grows 22.5% YoY, What About Adjusted EBITDA?
Friday, April 28, 2023 - 8:35am | 356Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT:M5B) (OTCMKTS:LFSWF) net revenue increased 22.5% to CA$5.9 million ($4.3 million) in Q1 2023 compared to CA$4.9 million in Q1 2022. The increase was driven by a CA$515,000, or 16.4%, increase in Canadian cannabis revenue and CA$551,000 contribution from...
-
Lifeist Q3 Revenue Grows 27% YoY, Driven By A 61% Increase In Canadian Cannabis Revenue
Friday, October 28, 2022 - 9:00am | 715Lifeist Wellness Inc. (OTCQB: NXTTF) (TSXV:LFST) (FRANKFURT:M5B) Q3 2022 net revenue increased 27% to CA$6.8 million ($5 million), compared to CA$5.4 million in Q3 2021. Third Quarter 2022 Highlights Net revenue increase was driven by a CA$1.8 million, or 61%, increase in Canadian cannabis...
-
Lifeist Wellness Reduces Net Los By 37.83% To $3.6M In Q1 2022
Friday, April 29, 2022 - 2:07pm | 660Lifeist Wellness Inc. (OTCQB: NXTTF) (TSXV: LFST) (FRANKFURT: M5B) released its financial results for the three months ended February 28, 2022 (“Q1 2022”) compared to the same period last year (“Q1 2021”). Q1 2022 Highlights Net revenue decreased 1% to CA$5.45 million ($4....
-
Lifeist Portfolio Co. Mikra Launches Presales Of CELLF To Help Combat Fatigue, Inflammation & Brain Fog
Wednesday, March 9, 2022 - 10:48am | 407Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTC: NXTTF) announced several business updates regarding its wholly owned U.S. subsidiary, Mikra, Cellular Sciences Inc., including the commencement of presales in the U.S. for its novel cellular therapeutic compound, CELLF, targeted at combating...